Henrik DamkjÆr Simonsen
CHIEF FINANCIAL OFFICER
Biopharmaceuticals
Nuevolution
Denmark
Biography
Henrik Simonsen, Chief Financial Officer, joined Nuevolution in August 2015. He has extensive experience as analyst of pharmaceutical and biotech companies, experience from IPOs of life science companies in Denmark, Sweden, UK and Belgium, and M&A experience from transactions with Nordic life science companies. His most recent position was at SEB, where he was Director, responsible for life science, in SEB Corporate Finance. Prior to that, he was senior analyst at SEB Equities (2004-11). From 1990-2004, he was equity analyst and senior equity analyst at Nordea Securities. Henrik received his MSc. in Economics from the University of Copenhagen.
Research Interest
Focusing on delivering breakthrough medicines for treatment of cancer and inflammatory diseases
